Got a new idea?   |   PMR Publications   |   PMR Consulting   |   PMR Research   |   PMR Online Access
 
 

The clinical trials market in CIS countries continues to grow - February 2012

Clinical trials in the CIS countries have been developing in a positive fashion (with the exception of Russia, whose development slowed for a while as a result of significant changes in regulations). The expected average growth in value will reach 14% and approximately 13% by volume in the years 2012-2014, according to the newest PMR Publications report “Clinical trials in CIS countries 2012 – Russia, Ukraine, Belarus and Georgia. Development forecasts for 2012-2014”. Despite some turmoil in legislation, the countries will attract investors due to relatively low costs and large population willing to participate in clinical trials.

According to our estimates, the total clinical trials market value in the CIS countries analysed exceeded $532m (€403m) in 2010 and reached $633 (€479m) in 2011 (an increase by 19% y-o-y). The largest proportion of this value was accounted by Russia – 63%, and Ukraine – 33% in 2011.

To open the FULL free article/document, please sign up.

*required

*Email:
To make sure you receive the requested information, add info@pmrcorporate.com to your company trusted emails. Contact your IT department for details.
*Your company core business:
Help us better answer your needs.
Why do you sign up?
Please specify:

Privacy Policy


 
People who downloaded this free article, have read also:
More information on this topic in PMR product:
The report analyses the conditions for conducting clinical trials. It presents key facts regarding the market?s size (number of clinical trials, value of the market) and condition. It provides data on: key trends and circumstances affecting the sector, present-day market size with forecasts for 2012-2014. It reveals the following information: the current and anticipated situation on the market, market growth opportunities and obstacles, the average registration time for clinical trials, main characteristics and market standing of major companies conducting clinical trials The report also includes a comparative analysis of conditions governing the performance of clinical trials in the CIS countries analysed. The operations of major pharmaceutical corporations active in CIS are then presented, with special attention given to number of trials, location, and therapeutic areas.
more »
 
About us         Contact us         Privacy Policy
Copyright © 2012 PMR. All rights reserved.

PMR is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.